Paper · 40468460
References533
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 533
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36755314 | Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36755314 | PubMed |
| 2 | 38724526 | Glioma. | Nat Rev Dis Primers | 2024 | https://conductscience.org/library/papers/38724526 | PubMed |
| 3 | 39544152 | BRD4 Degradation Enhanced Glioma Sensitivity to Temozolomide by Regulating Notch1 via Glu-Modified GSH-Responsive Nanoparticles. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39544152 | PubMed |
| 4 | 37382632 | Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/37382632 | PubMed |
| 5 | 35836243 | PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35836243 | PubMed |
| 6 | 32641768 | Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. | Nat Commun | 2020 | https://conductscience.org/library/papers/32641768 | PubMed |
| 7 | 38981438 | Multi-scale signaling and tumor evolution in high-grade gliomas. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38981438 | PubMed |
| 8 | 32973101 | A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma. | Mol Cancer Res | 2021 | https://conductscience.org/library/papers/32973101 | PubMed |
| 9 | 36195821 | Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma. | Pharm Res | 2022 | https://conductscience.org/library/papers/36195821 | PubMed |
| 10 | 31263673 | C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage. | Front Oncol | 2019 | https://conductscience.org/library/papers/31263673 | PubMed |
| 11 | 39170552 | Navigating the neurological frontier: Macromolecular marvels in overcoming blood-brain barrier challenges for advanced drug delivery. | Heliyon | 2024 | https://conductscience.org/library/papers/39170552 | PubMed |
| 12 | 32872164 | Fatty Acid Synthase: An Emerging Target in Cancer. | Molecules | 2020 | https://conductscience.org/library/papers/32872164 | PubMed |
| 13 | 30506499 | Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial. | J Neurooncol | 2019 | https://conductscience.org/library/papers/30506499 | PubMed |
| 14 | 39567689 | Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma. | Nature | 2024 | https://conductscience.org/library/papers/39567689 | PubMed |
| 15 | 35205750 | PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35205750 | PubMed |
| 16 | 34305910 | Immune Checkpoint Inhibitors in Human Glioma Microenvironment. | Front Immunol | 2021 | https://conductscience.org/library/papers/34305910 | PubMed |
| 17 | 37178737 | Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma. | Gastroenterology | 2023 | https://conductscience.org/library/papers/37178737 | PubMed |
| 18 | 35760272 | Nanomedicine for glioblastoma: Progress and future prospects. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35760272 | PubMed |
| 19 | 31601097 | Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma. | ACS Appl Mater Interfaces | 2019 | https://conductscience.org/library/papers/31601097 | PubMed |
| 20 | 34696786 | Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34696786 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/40468460/references